A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. (Q54058828)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. |
scientific article |
Statements
A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome. (English)
1 reference
J M Cunningham
1 reference
H Blaszyk
1 reference
A Hartmann
1 reference
D Schaid
1 reference
L E Wold
1 reference
J S Kovach
1 reference
S S Sommer
1 reference
1 January 2000
1 reference
89
1 reference
1
1 reference
32-38
1 reference
Identifiers
1 reference